Oct 21, 2025 04:05PM
Oct 21, 2025 04:05PM
Aug 7, 2025 04:05PM
Sep 19, 2024 08:00AM
Aug 7, 2024 04:05PM
May 8, 2024 04:05PM
Feb 27, 2024 04:05PM Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Feb 7, 2024 07:02AM
Feb 7, 2024 07:00AM
Nov 7, 2023 04:05PM
Oct 27, 2023 07:00AM
Sep 7, 2023 07:00AM
Aug 3, 2023 04:05PM
Nov 29, 2022 11:08AM Alector (ALEC) Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases
Nov 29, 2022 11:05AM
Nov 29, 2022 11:05AM
Sep 9, 2022 05:34AM
Mar 15, 2022 08:01AM
Mar 15, 2022 08:00AM
Mar 15, 2022 08:00AM
Nov 12, 2021 01:51PM Alector Inc. (ALEC) Presents Encouraging New AL001 Data from the Symptomatic FTD-GRN Cohort of INFRONT-2 Phase 2 Open-label Clinical Study
Nov 12, 2021 01:50PM
Nov 12, 2021 01:50PM
Nov 10, 2021 08:30AM
Nov 10, 2021 08:30AM
Nov 4, 2021 04:05PM
Nov 4, 2021 04:05PM
Sep 9, 2021 08:30AM Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL001 in Amyotrophic Lateral Sclerosis (ALS)
Sep 9, 2021 08:30AM
Jul 29, 2021 10:12AM
Jul 29, 2021 10:10AM
Jul 29, 2021 10:10AM
Jul 2, 2021 09:29AM
Jul 2, 2021 08:00AM
Jul 2, 2021 07:38AM Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases
Jul 2, 2021 07:38AM
Jun 2, 2021 06:31AM
Jun 2, 2021 06:31AM
May 26, 2021 04:05PM
May 26, 2021 04:05PM
Feb 25, 2021 04:05PM
Feb 25, 2021 04:05PM Alector Reports 2020 Fourth Quarter and Full Year Financial Results and Provides Business Update
Jul 29, 2020 05:53AM
Jul 28, 2020 06:00PM
Jul 28, 2020 06:00PM
Jul 24, 2020 08:34AM
Jul 24, 2020 08:30AM
Jul 24, 2020 08:30AM
Mar 24, 2020 04:05PM Alector Reports 2019 Fourth Quarter and Full Year Financial Results and Business Highlights
Mar 24, 2020 04:05PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All